MindMaze has launched Izar, a first-of-its-kind smart peripheral for hand dexterity assessment and training, in the European Union (EU) and the US.
The new peripheral has been designed to fill a critical gap in neurological care and aims to provide strength treatment for a broad range of neurological conditions.
It is said to be part of a complete, omnisite approach to neurological disease maintenance and treatment for conditions including Alzheimer’s disease, Traumatic Brain Injury (TBI), Parkinson’s disease and stroke.
Izar is developed to train and evaluate dexterity and strength by capturing the fine grasp forces and wrist movements that are required for carrying out daily living activities.
It is a hyper-sensitive controller that allows clinics to address the unmet hand recovery requirements by providing either new in-clinic treatments or remotely supervised self-training programmes for patients at home.
The peripheral can detect the finger and hand forces of sub-newton level patients and enables treatment of the most impaired patients.
MindMaze chief medical director and professor John Krakauer said: “It is very exciting to have a device for the hand that has the versatility of Izar.
“It can serve as a controller during reach-to-grasp movements, as a trainer of grip force gradation and as an assessor of dexterity.
“The device is also highly portable, so it can be used across the continuum of care, which is important as the upper limb, and the hand in particular, gets relatively neglected in neurorehabilitation.”
Izar also includes engaging gaming content that allows patients to self-train, either in-clinic or at home. This helps to improve and expand training opportunities.
The new peripheral is now available in the US as well as European countries, including Germany, Switzerland and France, with content that enables training for dexterous pinch, grip and grasp.